These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1288089)

  • 1. Improvement of pulmonary gas exchange after surfactant replacement in rats with Pneumocystis carinii pneumonia.
    Eijking EP; van Daal GJ; Tenbrinck R; Sluiters JF; Hannappel E; Erdmann W; Lachmann B
    Adv Exp Med Biol; 1992; 316():293-8. PubMed ID: 1288089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.
    Eijking EP; van Daal GJ; Tenbrinck R; Luijendijk A; Sluiters JF; Hannappel E; Lachmann B
    Intensive Care Med; 1991; 17(8):475-8. PubMed ID: 1797892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.
    Creery WD; Hashmi A; Hutchison JS; Singh RN
    Pediatr Pulmonol; 1997 Nov; 24(5):370-3. PubMed ID: 9407571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
    Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
    Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.
    Atochina EN; Beers MF; Scanlon ST; Preston AM; Beck JM
    Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L599-609. PubMed ID: 10710533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia.
    van Daal GJ; So KL; Gommers D; Eijking EP; Fiévez RB; Sprenger MJ; van Dam DW; Lachmann B
    Anesth Analg; 1991 May; 72(5):589-95. PubMed ID: 1850209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
    Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
    Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.
    Phelps DS; Umstead TM; Rose RM; Fishman JA
    Eur Respir J; 1996 Mar; 9(3):565-70. PubMed ID: 8730021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Dinger J; Töpfer A; Schaller P; Schwarze R
    Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.
    Wright TW; Notter RH; Wang Z; Harmsen AG; Gigliotti F
    Infect Immun; 2001 Feb; 69(2):758-64. PubMed ID: 11159965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour Pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats.
    Vives MF; Caspar-Bauguil S; Aliouat EM; Escamilla R; Perret B; Dei-Cas E; Prévost MC
    Parasite; 2008 Mar; 15(1):53-64. PubMed ID: 18416247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia.
    Hughes WT; Sillos EM; LaFon S; Rogers M; Woolley JL; Davis C; Studenberg S; Pattishall E; Freeze T; Snyder G; Staton S
    J Infect Dis; 1998 Apr; 177(4):1046-56. PubMed ID: 9534981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
    Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
    J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary function tests after pneumocystis carinii pneumonia in HIV infected patients].
    Pothoff G; Wassermann K; Julius B; Hilger HH
    Pneumologie; 1992 Jun; 46(6):221-5. PubMed ID: 1495909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical look at the surfactant therapy: when, how much, and what to use?
    Pappert D; Rossaint R
    Acta Anaesthesiol Scand Suppl; 1997; 111():74-7. PubMed ID: 9420961
    [No Abstract]   [Full Text] [Related]  

  • 18. Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.
    Putz G; Hörmann C; Koller W; Schön G
    Intensive Care Med; 1996 Jun; 22(6):588-90. PubMed ID: 8814477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat.
    Rice WR; Singleton FM; Linke MJ; Walzer PD
    J Clin Invest; 1993 Dec; 92(6):2778-82. PubMed ID: 8254031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia.
    Slater AJ; Nichani SH; Macrae D; Wilkinson KA; Novelli V; Tasker RC
    Intensive Care Med; 1995 Mar; 21(3):261-3. PubMed ID: 7790617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.